In Asia Pacific, China is a major market for asthma drugs due to rapid urbanization, pollution levels, and changing lifestyle leading to higher incidence of asthma. Japan and South Korea are also key markets for asthma drugs, with growing healthcare expenditure and rising geriatric population driving the demand for asthma treatments.
In Europe, the United Kingdom is a prominent market for asthma drugs, with a well-established healthcare system and high prevalence of asthma among the population. Germany and France are also significant markets for asthma drugs, driven by increasing adoption of advanced therapies and rising awareness about the disease among healthcare professionals and patients.